{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:08:15Z","timestamp":1790953695983,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2321-B-182A-005"],"award-info":[{"award-number":["NSTC113-2321-B-182A-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01851-2","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T02:59:47Z","timestamp":1755658787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Hsin-I","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Chia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Gue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"1851_CR1","doi-asserted-by":"crossref","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024.","DOI":"10.1002\/alz.13859"},{"key":"1851_CR2","first-page":"434","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, Cash DM, Coath W, Lane CA, Parker TD, et al. Population-based blood screening for preclinical alzheimer\u2019s disease in a British birth cohort at age 70. Brain. 2021;144:434\u201349.","journal-title":"Brain"},{"key":"1851_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.14283\/jpad.2020.44","volume":"7","author":"O Langford","year":"2020","unstructured":"Langford O, Raman R, Sperling RA, Cummings J, Sun CK, Jimenez-Maggiora G, Aisen PS, Donohue MC. Predicting amyloid burden to accelerate recruitment of secondary prevention clinical trials. J Prev Alzheimers Dis. 2020;7:213\u20138.","journal-title":"J Prev Alzheimers Dis"},{"key":"1851_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","volume":"3","author":"WS Brum","year":"2023","unstructured":"Brum WS, Cullen NC, Janelidze S, Ashton NJ, Zimmer ER, Therriault J, Benedet AL, Rahmouni N, Tissot C, Stevenson J, et al. A two-step workflow based on plasma p-tau217 to screen for amyloid beta positivity with further confirmatory testing only in uncertain cases. Nat Aging. 2023;3:1079\u201390.","journal-title":"Nat Aging"},{"key":"1851_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","volume":"79","author":"MJ Pontecorvo","year":"2022","unstructured":"Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, Collins EC, Sims JR, Mintun MA. Association of Donanemab treatment with exploratory plasma biomarkers in early symptomatic alzheimer disease: A secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 2022;79:1250\u20139.","journal-title":"JAMA Neurol"},{"key":"1851_CR6","doi-asserted-by":"publisher","first-page":"e14297","DOI":"10.1002\/alz.14297","volume":"21","author":"KL Huang","year":"2025","unstructured":"Huang KL, Hsiao IT, Huang CW, Huang CG, Chang HI, Huang SH, Lin KJ, Ma MC, Huang CC, Chang CC. The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of alzheimer\u2019s disease and Tau burden. Alzheimers Dement. 2025;21:e14297.","journal-title":"Alzheimers Dement"},{"key":"1851_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A, Sanchez-Benavides G, Minguillon C, Fauria K, Molinuevo JL, Grau-Rivera O, Gonzalez Escalante A, Kollmorgen G, et al. Astrocyte biomarkers GFAP and YKL-40 mediate early alzheimer\u2019s disease progression. Alzheimers Dement. 2024;20:483\u201393.","journal-title":"Alzheimers Dement"},{"key":"1851_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dore V, Singh AK, Wang P, Rainey-Smith S, Fowler C, et al. Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19:1117\u201334.","journal-title":"Alzheimers Dement"},{"key":"1851_CR9","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/dad2.12295","volume":"14","author":"A Dittrich","year":"2022","unstructured":"Dittrich A, Ashton NJ, Zetterberg H, Blennow K, Simren J, Geiger F, Zettergren A, Shams S, Machado A, Westman E, et al. Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds. Alzheimers Dement (Amst). 2022;14:e12295.","journal-title":"Alzheimers Dement (Amst)"},{"key":"1851_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1109\/JBHI.2020.2984355","volume":"25","author":"CS Eke","year":"2021","unstructured":"Eke CS, Jammeh E, Li X, Carroll C, Pearson S, Ifeachor E. Early detection of alzheimer\u2019s disease with blood plasma proteins using support vector machines. IEEE J Biomed Health Inf. 2021;25:218\u201326.","journal-title":"IEEE J Biomed Health Inf"},{"key":"1851_CR11","doi-asserted-by":"publisher","first-page":"116085","DOI":"10.1016\/j.bios.2024.116085","volume":"250","author":"S Kim","year":"2024","unstructured":"Kim S, Ma X, Jeon MJ, Song S, Lee JS, Lee JU, Lee CN, Choi SH, Sim SJ. Distinct plasma phosphorylated-tau proteins profiling for the differential diagnosis of mild cognitive impairment and alzheimer\u2019s disease by plasmonic asymmetric nanobridge-based biosensor. Biosens Bioelectron. 2024;250:116085.","journal-title":"Biosens Bioelectron"},{"key":"1851_CR12","first-page":"1","volume":"2023","author":"S Luz","year":"2023","unstructured":"Luz S, Haider F, De Sousa P. Machine learning models for detection and assessment of progression in alzheimer\u2019s disease based on blood and cerebrospinal fluid biomarkers. Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1\u20134.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"1851_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-021-00942-0","volume":"14","author":"AL Benedet","year":"2022","unstructured":"Benedet AL, Brum WS, Hansson O, Alzheimer\u2019s Disease Neuroimaging I, Karikari TK, Zimmer ER, Zetterberg H, Blennow K, Ashton NJ. The accuracy and robustness of plasma biomarker models for amyloid PET positivity. Alzheimers Res Ther. 2022;14:26.","journal-title":"Alzheimers Res Ther"},{"key":"1851_CR14","doi-asserted-by":"crossref","unstructured":"Xiao Z, Zhou X, Zhao Q, Cao Y, Ding D. Significance of plasma p-tau217 in predicting long-term dementia risk in older community residents: insights from machine learning approaches. Alzheimers Dement. 2024;20(10):7037\u201347.","DOI":"10.1002\/alz.14178"},{"key":"1851_CR15","doi-asserted-by":"publisher","first-page":"fcae081","DOI":"10.1093\/braincomms\/fcae081","volume":"6","author":"KL Meeker","year":"2024","unstructured":"Meeker KL, Luckett PH, Barthelemy NR, Hobbs DA, Chen C, Bollinger J, Ovod V, Flores S, Keefe S, Henson RL, et al. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in alzheimer\u2019s disease. Brain Commun. 2024;6:fcae081.","journal-title":"Brain Commun"},{"key":"1851_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319:1317\u20138.","journal-title":"JAMA"},{"key":"1851_CR17","first-page":"1805","volume":"38","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J. 2017;38:1805\u201314.","journal-title":"Eur Heart J"},{"key":"1851_CR18","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMp1702071","volume":"376","author":"JH Chen","year":"2017","unstructured":"Chen JH, Asch SM. Machine learning and prediction in Medicine - Beyond the peak of inflated expectations. N Engl J Med. 2017;376:2507\u20139.","journal-title":"N Engl J Med"},{"key":"1851_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","volume":"110","author":"E Christodoulou","year":"2019","unstructured":"Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12\u201322.","journal-title":"J Clin Epidemiol"},{"key":"1851_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/pcn.13557","volume":"77","author":"HI Chang","year":"2023","unstructured":"Chang HI, Huang CW, Hsu SW, Huang SH, Lin KJ, Ho TY, Ma MC, Hsiao WC, Chang CC. Gray matter reserve determines glymphatic system function in young-onset alzheimer\u2019s disease: evidenced by DTI-ALPS and compared with age-matched controls. Psychiatry Clin Neurosci. 2023;77:401\u20139.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1851_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/pcn.13680","volume":"78","author":"HI Chang","year":"2024","unstructured":"Chang HI, Huang CW, Huang SH, Hsu SW, Lin KJ, Ho TY, Wu HC, Chang CC. Distinct biological property of Tau in Tau-first cognitive proteinopathy: evidence by longitudinal clinical neuroimaging profiles and compared with late-onset alzheimer disease. Psychiatry Clin Neurosci. 2024;78:446\u201355.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1851_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnagi.2019.00220","volume":"11","author":"T Jo","year":"2019","unstructured":"Jo T, Nho K, Saykin AJ. Deep learning in alzheimer\u2019s disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci. 2019;11:220.","journal-title":"Front Aging Neurosci"},{"key":"1851_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33\u20139.","journal-title":"Arch Neurol"},{"key":"1851_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"1851_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670\u20136.","journal-title":"Neurology"},{"key":"1851_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853\u201364.","journal-title":"Mov Disord"},{"key":"1851_CR27","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson AL, Strandberg O, Mengel D, Walsh DM, Stomrud E, Dage JL, Hansson O. Longitudinal plasma p-tau217 is increased in early stages of alzheimer\u2019s disease. Brain. 2020;143:3234\u201341.","journal-title":"Brain"},{"key":"1851_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Stomrud E, Smith R, Palmqvist S, Mattsson N, Airey DC, Proctor NK, Chai X, Shcherbinin S, Sims JR, et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of alzheimer\u2019s disease. Nat Commun. 2020;11:1683.","journal-title":"Nat Commun"},{"key":"1851_CR29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Sabbagh M, Cohen S. Lecanemab in early alzheimer\u2019s disease. Reply. N Engl J Med. 2023;388:1631\u20132.","journal-title":"N Engl J Med"},{"key":"1851_CR30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, et al. Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"1851_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-3-031-31982-2_31","volume":"1424","author":"NN Mohammed","year":"2023","unstructured":"Mohammed NN. Improved regularized Multi-class logistic regression for gene classification with optimal kernel PCA and HC algorithm. Adv Exp Med Biol. 2023;1424:273\u20139.","journal-title":"Adv Exp Med Biol"},{"key":"1851_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neunet.2020.08.024","volume":"132","author":"HA Le Thi","year":"2020","unstructured":"Le Thi HA, Le HM, Phan DN, Tran B. Stochastic DCA for minimizing a large sum of DC functions with application to multi-class logistic regression. Neural Netw. 2020;132:220\u201331.","journal-title":"Neural Netw"},{"key":"1851_CR33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awae104","volume":"147","author":"C Limberger","year":"2024","unstructured":"Limberger C, Zimmer ER. Blood GFAP reflects astrocyte reactivity to alzheimer\u2019s pathology in post-mortem brain tissue. Brain. 2024;147:1598\u2013600.","journal-title":"Brain"},{"key":"1851_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2023.04.004","volume":"524","author":"WC Hsiao","year":"2023","unstructured":"Hsiao WC, Chang HI, Hsu SW, Lee CC, Huang SH, Cheng CH, Huang CW, Chang CC. Association of cognition and brain reserve in aging and glymphatic function using diffusion tensor Image-along the perivascular space (DTI-ALPS). Neuroscience. 2023;524:11\u201320.","journal-title":"Neuroscience"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01851-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01851-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01851-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:36:05Z","timestamp":1757439365000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01851-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1851"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01851-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of the Chang Gung Memorial Hospital and is conducted in accordance with the latest Declaration of Helsinki Manuscripts, including written informed consent from all participants. We confirmed that all human subjects provided informed consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}